Agitation Medication Dementia: Safe, Effective Options

When a loved one with dementia becomes restless or irritable, the urge to find a quick fix is real. The good news? The most reliable calming meds aren't a mysterythey're low-dose risperidone, the newly approved Rexulti (brexpiprazole), and a handful of carefully chosen SSRIs. Each works differently, comes with its own safety checklist, and can be part of a balanced plan that respects both the person's dignity and your peace of mind.

Choosing the right medication isn't just about shutting someone down. It's about weighing benefits against risks, involving the care team, and staying attuned to the day-to-day realities of life with dementia. Below is a friendly, no-jargon guide that walks you through what works, what to watch out for, and how to talk with your doctor so you feel confident about the next steps.

Quick Answer

What is the best medication for agitation in dementia?

Risperidone (starting at 0.25mg nightly) has the strongest evidence for overall effectiveness, while brexpiprazole (Rexulti) is the only FDA-approved drug specifically for Alzheimer's-related agitation. If you're looking for a gentler start, low-dose SSRIs such as citalopram or sertraline can also help, especially when mood issues are present.

Key points at a glance

• First-line: Low-dose risperidone or brexpiprazole.
• Gentler alternatives: SSRIs (citalopram, sertraline).
• Avoid: High-dose benzodiazepines, typical antipsychotics, strong anticholinergics.
• Monitor: Falls, sedation, heart rhythm, weight changes.

Understanding Agitation

Why does agitation happen?

Think of agitation as a storm that can be sparked by many thingspain, infection, a noisy environment, unmet needs, or even the simple frustration of not being able to communicate. When the brain's chemistry gets thrown off, the person may become restless, aggressive, or unusually anxious.

How do we measure it?

Clinicians often use tools like the Neuropsychiatric Inventory-Aggression subscale (NPI-A) or the Cohen-Mansfield Agitation Inventory (CMAI). These scales turn vague behaviors into numbers, helping doctors decide whether a medication is actually making a difference.

Medication is only part of the puzzle

Nonpharmacologic strategiesconsistent routines, soothing music, proper lighting, and caregiver trainingshould come first. Meds are added when these measures aren't enough or when agitation poses safety risks. Whenever considering drug interventions, it's essential to be aware of black box warning information and monitor for serious drug safety warnings.

First-Line Options

SSRIs (Selective Serotonin Reuptake Inhibitors)

SSRIs are often a gentle entry point, especially if depression coexists with irritation. Common choices include:

• Citalopram start 10mg daily, may go up to 20mg. Watch QT interval if you exceed 40mg.
• Sertraline 25mg daily, titrate to 50mg.
• Escitalopram 5mg daily, can increase to 10mg.

These drugs modestly reduce agitation (about a 12 point drop on the NPI-A) and are generally safer than antipsychotics, but they don't work for everyone.

Atypical Antipsychotics When are they appropriate?

If agitation is severe, poses a danger, or doesn't respond to SSRIs, atypical antipsychotics become an option. The big three you'll hear about are:

Drug	Typical Starting Dose	Key Benefits	Major Risks
Risperidone	0.25mg nightly	Best-studied, moderate efficacy	Stroke risk, weight gain, sedation
Aripiprazole	2mg daily	Less sedation	Akathisia, metabolic changes
Olanzapine	2.5mg nightly	Strong calming effect	Significant weight gain, diabetes risk

Remember, the FDA requires a clear justification for using any antipsychotic in dementia, and the treatment should be reassessed after 46 weeks.

FDA-Approved & Emerging Treatments

Brexpiprazole (Rexulti) The only approved drug for Alzheimer's agitation

In 2021, the FDA gave brexpiprazole the green light for agitation linked to Alzheimer's disease. It starts at 1mg daily and can be raised to 2mg if needed. Clinical trials showed about a 5-point improvement on the NPI-A compared with placebo, and the side-effect profile is relatively mildmostly mild weight gain or occasional restlessness.

Off-label options worth a glance

Some clinicians still turn to older drugs when other options fail:

• Haloperidol rapid calming, but high risk of extrapyramidal symptoms (tremor, stiffness).
• Mirtazapine may help with sleep and appetite, but evidence for agitation is limited.
• Buspirone an anxiolytic with a low sedation profile, yet data are sparse.

These are generally considered only after a careful risk-benefit discussion.

Balancing Benefits & Risks

How to decide if the benefit outweighs the risk

Ask yourself these quick questions before starting a drug:

1. How severe is the agitation? (Mild, moderate, severe)
2. Are there underlying medical issues (heart disease, liver problems, fall history)?
3. What is the caregiver's capacity to manage side-effects?
4. Has a nonpharmacologic plan been tried for at least 46 weeks?

If the answer points to a high risk of injury or severe distress, a low-dose antipsychotic may be justified.

Key safety concerns per drug class

• Antipsychotics Increased risk of stroke and mortality in dementia patients (see drug safety warnings for more details).
• SSRIs Potential QT prolongation with high-dose citalopram; drug interactions via CYP450.
• Brexpiprazole May cause weight gain and akathisia; monitor weight and movement.

Real-World Experiences

Case A Nighttime agitation in moderate Alzheimer's

Mrs. L, 78, was tossing and turning every night, yelling at the TV. Her family tried citalopram 10mg, but the storm didn't calm. Switching to risperidone 0.25mg at bedtime led to a noticeable reduction in nighttime episodes within a week, and there were no falls over the next month.

Case B Aggression in vascular dementia

Mr. T, 70, displayed sudden outbursts when his routine was interrupted. After a thorough workup, his neurologist started brexpiprazole 1mg daily. Over three weeks, his NPI-A score dropped by 30%, and his family reported feeling much safer during visits.

What caregivers say

I felt like I was walking on eggshells. The medication gave us back some evenings for a peaceful dinner. Linda, daughter of a dementia patient.

Medication Interactions & Do-Not-Use List

Which drugs should you avoid mixing?

Mixing antipsychotics with benzodiazepines can dramatically increase fall risk and sedation. Strong CYP2D6 inhibitors (e.g., paroxetine) can raise brexpiprazole levels, leading to more side effects, and it's important to be aware of serious drug side effects when combining medications.

Quick Do-Not-Use checklist

• High-dose anticholinergics (e.g., diphenhydramine).
• Typical antipsychotics like haloperidol >2mg without specialist oversight.
• Long-acting benzodiazepines (e.g., diazepam) in frail elders.

Talking With Your Healthcare Team

Questions to ask your doctor

When you sit down with the prescriber, consider these prompts:

• What is the specific goal for this medication?
• How will we monitor for side effects?
• When should we consider tapering or stopping?
• Are there non-drug strategies we should keep trying?

When to request a medication review

Schedule a check-in after 46 weeks of any new med, after any adverse event (e.g., a fall or new confusion), or whenever agitation seems to worsen despite treatment.

Bottom-Line Takeaways

1. Evidence-based meds Risperidone and brexpiprazole lead the field, while SSRIs offer a gentler, mood-focused option.

2. Balance is key Every drug carries specific risks; match the choice to the severity of agitation, medical history, and caregiver capacity.

3. Stay collaborative Regular medication reviews, clear communication with your care team, and a solid nonpharmacologic foundation give the best chance for calm, safety, and quality of life.

If you've found a medication that's working, or if you're wrestling with tough decisions, share your story in the comments. Your experience could be the lifeline another family needs. And if you have questions, don't hesitate to asktogether we can navigate this challenging journey.